Percheron Therapeutics Limited (ASX:PER)

Percheron Therapeutics Statistics

Total Valuation

ASX:PER has a market cap or net worth of AUD 7.61 million. The enterprise value is 3.17 million.

Market Cap	7.61M
Enterprise Value	3.17M

Important Dates

The last earnings date was Friday, February 27, 2026.

Earnings Date	Feb 27, 2026
Ex-Dividend Date	n/a

Share Statistics

ASX:PER has 1.09 billion shares outstanding. The number of shares has increased by 12.30% in one year.

Current Share Class	1.09B
Shares Outstanding	1.09B
Shares Change (YoY)	+12.30%
Shares Change (QoQ)	-2.58%
Owned by Insiders (%)	20.36%
Owned by Institutions (%)	9.77%
Float	780.50M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	4.38
PB Ratio	1.07
P/TBV Ratio	1.88
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-0.33
EV / Sales	1.82
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-0.32

Financial Position

The company has a current ratio of 6.29, with a Debt / Equity ratio of 0.00.

Current Ratio	6.29
Quick Ratio	5.96
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	-0.00
Interest Coverage	-654.14

Financial Efficiency

Return on equity (ROE) is -84.63% and return on invested capital (ROIC) is -52.62%.

Return on Equity (ROE)	-84.63%
Return on Assets (ROA)	-45.87%
Return on Invested Capital (ROIC)	-52.62%
Return on Capital Employed (ROCE)	-132.77%
Weighted Average Cost of Capital (WACC)	11.51%
Revenue Per Employee	217,210
Profits Per Employee	-1.19M
Employee Count	8
Asset Turnover	0.13
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -22.22% in the last 52 weeks. The beta is 1.30, so ASX:PER's price volatility has been higher than the market average.

Beta (5Y)	1.30
52-Week Price Change	-22.22%
50-Day Moving Average	0.01
200-Day Moving Average	0.01
Relative Strength Index (RSI)	43.14
Average Volume (20 Days)	691,720

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ASX:PER had revenue of AUD 1.74 million and -9.49 million in losses. Loss per share was -0.01.

Revenue	1.74M
Gross Profit	1.55M
Operating Income	-9.48M
Pretax Income	-9.49M
Net Income	-9.49M
EBITDA	-9.43M
EBIT	-9.48M
Loss Per Share	-0.01

Balance Sheet

The company has 4.46 million in cash and 10,682 in debt, with a net cash position of 4.45 million or 0.00 per share.

Cash & Cash Equivalents	4.46M
Total Debt	10,682
Net Cash	4.45M
Net Cash Per Share	0.00
Equity (Book Value)	7.14M
Book Value Per Share	0.01
Working Capital	4.04M

Cash Flow

In the last 12 months, operating cash flow was -9.78 million and capital expenditures -3,581, giving a free cash flow of -9.78 million.

Operating Cash Flow	-9.78M
Capital Expenditures	-3,581
Free Cash Flow	-9.78M
FCF Per Share	-0.01

Margins

Gross Margin	89.17%
Operating Margin	-545.40%
Pretax Margin	-546.23%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ASX:PER does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-12.30%
Shareholder Yield	-12.30%
Earnings Yield	-124.69%
FCF Yield	-128.49%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on November 6, 2013. It was a reverse split with a ratio of 0.1.

Last Split Date	Nov 6, 2013
Split Type	Reverse
Split Ratio	0.1

Scores

ASX:PER has an Altman Z-Score of -14.05 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-14.05
Piotroski F-Score	2